Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Schuth Alexander O.. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Schuth Alexander O. har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:DNLI / Denali Therapeutics Inc. COFO and Secretary 242 346
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Schuth Alexander O.. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Schuth Alexander O. som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-08-14 2025-08-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 937 242 346 −1,20 13,58 −39 884 3 291 059
2025-01-08 2025-01-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 907 244 308 −1,18 20,81 −60 495 5 084 049
2025-01-08 2025-01-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −12 255 247 215 −4,72 20,22 −247 796 4 998 687
2025-01-07 2025-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 54 180 259 470 26,39
2024-12-31 2024-12-27 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 6 708 205 290 3,38 5,28 35 418 1 083 931
2024-11-26 2024-11-22 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 20 516 198 582 11,52 0,68 13 951 135 036
2024-11-12 2024-11-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −300 178 066 −0,17 31,29 −9 387 5 571 685
2024-11-12 2024-11-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 925 178 366 −1,61 30,72 −89 856 5 479 404
2024-11-12 2024-11-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −12 333 181 291 −6,37 29,68 −366 043 5 380 717
2024-11-12 2024-11-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 15 558 193 624 8,74 5,28 82 146 1 022 335
2024-08-22 2024-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 547 178 066 −1,41 24,78 −63 115 4 412 475
2024-08-22 2024-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −3 353 180 613 −1,82 23,54 −78 930 4 251 630
2024-08-22 2024-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 453 183 966 −1,32 23,79 −58 357 4 376 551
2024-08-15 2024-08-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 272 186 419 −1,20 22,89 −52 006 4 267 131
2024-02-15 2024-02-14 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −20 128 187 341 −9,70 17,66 −355 460 3 308 442
2024-02-15 2024-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 716 207 469 −1,29 17,29 −46 960 3 587 139
2024-02-12 2024-02-08 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 50 000 210 185 31,21 0,68 34 000 142 926
2024-01-09 2024-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −9 972 539 307 −1,82 19,43 −193 756 10 478 735
2024-01-05 2024-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 53 720 170 157 46,14
2023-08-25 2023-08-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 522 518 989 −0,48 23,17 −58 435 12 024 975
2023-08-23 2023-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 478 521 511 −0,47 22,59 −55 978 11 780 933
2023-08-16 2023-08-14 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 772 518 989 −0,53 23,67 −65 613 12 284 470
2023-08-14 2023-08-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 853 521 761 −0,54 24,18 −68 986 12 616 181
2023-07-19 2023-07-18 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −9 702 518 989 −1,84 30,01 −291 157 15 574 860
2023-07-19 2023-07-17 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −10 000 528 691 −1,86 29,60 −296 000 15 649 254
2023-07-19 2023-07-17 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 10 000 538 691 1,89 5,28 52 800 2 844 288
2023-05-17 2023-05-15 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −800 528 691 −0,15 29,23 −23 384 15 453 638
2023-05-17 2023-05-15 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −9 200 529 491 −1,71 28,55 −262 660 15 116 968
2023-05-17 2023-05-15 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 10 000 538 691 1,89 5,28 52 800 2 844 288
2023-04-14 2023-04-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −4 898 528 691 −0,92 25,04 −122 646 13 238 423
2023-04-14 2023-04-13 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 4 898 533 589 0,93 5,28 25 861 2 817 350
2023-04-14 2023-04-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −5 102 528 691 −0,96 25,04 −127 754 13 238 423
2023-04-14 2023-04-12 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5 102 533 793 0,97 5,28 26 939 2 818 427
2023-02-15 2023-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −3 497 528 691 −0,66 30,09 −105 225 15 908 312
2023-02-15 2023-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 25 000 524 902 5,00 0,68 17 000 356 933
2023-02-10 2023-02-08 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −1 521 499 902 −0,30 30,89 −46 984 15 441 973
2023-01-19 2023-01-17 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −114 497 173 −0,02 29,87 −3 405 14 850 558
2023-01-19 2023-01-17 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −9 886 497 287 −1,95 29,53 −291 934 14 684 885
2023-01-19 2023-01-17 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 10 000 507 173 2,01 5,28 52 800 2 677 873
2023-01-09 2023-01-04 4/A DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 912 492 309 −0,59 28,70 −83 574 14 129 268
2023-01-09 2023-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 636 497 173 −0,53 28,44 −74 968 14 139 600
2023-01-05 2023-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 912 149 828 −1,91 28,70 −83 574 4 300 064
2023-01-05 2023-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 41 120 157 578 35,31
2022-10-12 2022-10-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 20 000 487 471 4,28 0,68 13 600 331 480
2022-08-23 2022-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 576 467 471 −0,55 33,22 −85 575 15 529 387
2022-08-11 2022-08-09 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 22 500 121 458 22,74
2022-02-15 2022-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 803 465 047 −0,60 34,68 −97 208 16 127 830
2022-02-11 2022-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −1 423 460 564 −0,31 37,10 −52 800 17 088 997
2022-01-07 2022-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 846 457 737 −0,62 44,77 −127 415 20 492 885
2022-01-05 2022-01-03 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 93 000 93 000
2022-01-05 2022-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 31 000 117 454 35,86
2021-12-08 2021-12-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −7 200 453 083 −1,56 42,45 −305 640 19 233 373
2021-12-08 2021-12-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 800 460 283 −0,60 41,82 −117 096 19 249 035
2021-11-08 2021-11-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −3 283 463 083 −0,70 53,23 −174 754 24 649 908
2021-11-08 2021-11-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −6 717 466 366 −1,42 52,65 −353 650 24 554 170
2021-10-06 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −4 006 473 083 −0,84 51,04 −204 466 24 146 156
2021-10-06 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −5 994 477 089 −1,24 50,24 −301 139 23 968 951
2021-09-22 2021-09-20 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise −9 045 240 078 −3,63
2021-09-22 2021-09-20 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 9 045 95 499 10,46 0,68 6 151 64 939
2021-09-09 2021-09-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 441 474 038 −0,51 56,05 −136 818 26 569 830
2021-09-09 2021-09-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −5 350 476 479 −1,11 55,67 −297 834 26 525 586
2021-09-09 2021-09-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 209 481 829 −0,46 54,70 −120 832 26 356 046
2021-08-23 2021-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −196 484 038 −0,04 50,10 −9 820 24 250 304
2021-08-23 2021-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 348 484 234 −0,48 49,56 −116 367 23 998 637
2021-08-06 2021-08-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −200 481 582 −0,04 52,99 −10 598 25 519 030
2021-08-06 2021-08-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −8 236 481 782 −1,68 52,34 −431 064 25 215 988
2021-08-06 2021-08-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 564 490 018 −0,32 51,52 −80 571 25 243 767
2021-07-08 2021-07-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −10 000 491 582 −1,99 76,20 −762 040 37 460 515
2021-06-08 2021-06-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −4 340 501 582 −0,86 64,82 −281 301 32 510 539
2021-06-08 2021-06-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −5 660 505 922 −1,11 64,35 −364 198 32 554 057
2021-05-06 2021-05-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −445 511 582 −0,09 57,39 −25 539 29 359 691
2021-05-06 2021-05-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −3 557 512 027 −0,69 55,92 −198 890 28 629 990
2021-05-06 2021-05-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −5 998 515 584 −1,15 55,09 −330 436 28 404 038
2021-04-06 2021-04-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −700 521 582 −0,13 57,44 −40 206 29 958 105
2021-04-06 2021-04-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −4 156 522 282 −0,79 56,46 −234 669 29 490 653
2021-04-06 2021-04-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −5 144 526 438 −0,97 55,60 −286 027 29 272 059
2021-03-04 2021-03-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 878 531 582 −0,35 61,58 −115 647 32 734 820
2021-03-04 2021-03-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −8 122 533 460 −1,50 60,89 −494 524 32 480 779
2021-02-16 2021-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −433 541 582 −0,08 71,41 −30 920 38 673 287
2021-02-16 2021-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −2 614 542 015 −0,48 70,17 −183 422 38 032 651
2021-02-11 2021-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −206 537 344 −0,04 75,68 −15 591 40 668 343
2021-02-11 2021-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −1 262 537 550 −0,23 74,66 −94 218 40 132 408
2021-02-11 2021-02-07 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise −4 250 8 500 −33,33
2021-02-11 2021-02-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 4 250 538 812 0,80
2021-02-05 2021-02-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 912 534 562 −0,36 68,61 −131 180 36 675 764
2021-02-05 2021-02-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −6 509 536 474 −1,20 67,90 −441 942 36 424 975
2021-02-05 2021-02-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 579 542 983 −0,29 66,65 −105 239 36 189 274
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 90 000 90 000
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 30 000 30 000
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 226 544 562 −0,22 84,17 −103 190 45 834 912
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 900 545 788 −0,35 82,96 −157 631 45 280 646
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −7 996 547 688 −1,44 82,14 −656 767 44 985 449
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 817 555 684 −0,50 81,45 −229 433 45 258 072
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −3 598 558 501 −0,64 79,78 −287 062 44 559 388
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −7 876 562 099 −1,38 78,42 −617 675 44 082 614
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 472 569 975 −0,26 77,64 −114 287 44 253 201
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −980 571 447 −0,17 76,41 −74 877 43 661 579
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −700 572 427 −0,12 75,61 −52 924 43 278 744
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −5 144 573 127 −0,89 74,01 −380 698 42 416 098
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −4 626 578 271 −0,79 73,09 −338 101 42 264 208
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −8 531 582 897 −1,44 72,22 −616 094 42 095 830
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −9 709 591 428 −1,62 71,03 −689 652 42 010 432
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −9 340 601 137 −1,53 70,10 −654 738 42 139 944
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 067 610 477 −0,17 69,07 −73 701 42 167 600
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −518 611 544 −0,08 67,78 −35 110 41 449 841
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 100 612 062 −0,18 66,58 −73 234 40 748 885
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 400 613 162 −0,23 65,17 −91 233 39 957 560
2020-11-30 2020-08-21 4/A DNLI Denali Therapeutics Inc.
Common Stock
F - Taxes −1 954 614 562 −0,32 32,88 −64 248 20 206 799
2020-11-30 2020-08-20 4/A DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5 643 616 516 0,92
2020-08-24 2020-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
F - Taxes −1 954 614 562 −0,32 32,88 −64 248 20 206 799
2020-08-24 2020-08-20 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise −5 643 0 −100,00
2020-08-24 2020-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5 643 616 516 0,92
2020-08-20 2020-08-18 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 20 000 20 000
2020-04-01 2020-03-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale −1 427 28 662 −4,74 19,49 −27 812 558 622
2020-04-01 2020-02-07 4/A DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise −4 250 12 750 −25,00
2020-04-01 2020-02-07 4/A DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 4 250 30 089 16,45
2020-02-12 2020-02-10 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 136 000 136 000
2020-02-12 2020-02-10 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 29 143 29 143
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise −3 121 108 937 −2,79
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −3 121 25 839 −10,78 18,00 −56 178 465 102
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 3 121 28 960 12,08 5,28 16 479 152 909
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 656 580 710 −0,46 18,00 −47 808 10 452 780
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise −711 112 058 −0,63
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −711 25 839 −2,68 18,01 −12 805 465 360
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 711 26 550 2,75 5,28 3 754 140 184
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 012 583 366 −0,17 18,01 −18 226 10 506 422
2019-11-26 2019-11-26 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −229 584 378 −0,04 18,02 −4 127 10 530 492
2019-11-26 2019-11-25 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −14 125 584 607 −2,36 18,02 −254 532 10 534 618
2019-11-26 2019-11-22 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −646 598 732 −0,11 18,00 −11 628 10 777 176
2019-10-25 2019-10-23 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise −5 129 112 769 −4,35
2019-10-25 2019-10-23 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5 129 25 839 24,77 5,28 27 081 136 430
2019-09-11 2019-09-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −7 500 610 089 −1,21 18,16 −136 200 11 079 216
2019-08-22 2019-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
F - Taxes −1 975 20 710 −8,71 18,60 −36 731 385 160
2019-08-22 2019-08-20 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise −5 643 5 643 −50,00
2019-08-22 2019-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5 643 22 685 33,11
2019-08-09 2019-08-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −7 500 617 589 −1,20 18,81 −141 075 11 616 849
2019-07-10 2019-07-08 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −400 625 089 −0,06 20,90 −8 360 13 064 360
2019-07-10 2019-07-08 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −7 100 625 489 −1,12 20,25 −143 775 12 666 152
2019-06-12 2019-06-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −7 500 632 589 −1,17 18,77 −140 775 11 873 696
2019-05-13 2019-05-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 640 089 −0,39 21,09 −52 725 13 499 477
2019-05-13 2019-05-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 642 589 −0,39 22,19 −55 475 14 259 050
2019-05-13 2019-05-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 645 089 −0,39 22,86 −57 150 14 746 735
2019-04-11 2019-04-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 512 647 589 −0,39 27,73 −69 658 17 957 643
2019-04-11 2019-04-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 513 650 101 −0,39 28,26 −71 017 18 371 854
2019-04-11 2019-04-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 475 652 614 −0,38 28,17 −69 721 18 384 136
2019-03-13 2019-03-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 512 655 089 −0,23 24,33 −36 787 15 938 315
2019-03-13 2019-03-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 000 656 601 −0,15 23,60 −23 600 15 495 784
2019-03-13 2019-03-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 513 657 601 −0,38 22,40 −56 291 14 730 262
2019-03-13 2019-03-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −275 660 114 −0,04 21,80 −5 995 14 390 485
2019-03-13 2019-03-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 200 660 389 −0,33 21,20 −46 640 14 000 247
2019-02-12 2019-02-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 700 662 589 −0,26 20,24 −34 408 13 410 801
2019-02-12 2019-02-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −800 664 289 −0,12 19,73 −15 784 13 106 422
2019-02-12 2019-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 266 665 089 −0,19 19,35 −24 497 12 869 472
2019-02-12 2019-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −1 234 666 355 −0,18 18,74 −23 125 12 487 493
2019-02-12 2019-02-08 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 667 589 −0,37 18,11 −45 275 12 090 037
2019-02-11 2019-02-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 136 000 136 000
2019-02-11 2019-02-07 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 17 000 17 000
2019-01-11 2019-01-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 670 089 −0,37 20,80 −52 000 13 937 851
2019-01-11 2019-01-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 672 589 −0,37 19,99 −49 975 13 445 054
2019-01-11 2019-01-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 675 089 −0,37 20,31 −50 775 13 711 058
2018-12-12 2018-12-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 677 589 −0,37 20,80 −52 000 14 093 851
2018-12-12 2018-12-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 680 089 −0,37 20,22 −50 550 13 751 400
2018-12-12 2018-12-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X −2 500 682 589 −0,36 20,18 −50 450 13 774 646
2018-10-03 2018-10-02 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise −5 859 56 641 −9,37
2018-10-03 2018-10-02 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise −1 184 117 898 −0,99
2018-10-03 2018-10-02 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5 859 12 961 82,50 9,60 56 246 124 426
2018-10-03 2018-10-02 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 1 184 7 102 20,01 5,28 6 252 37 499
2018-08-22 2018-08-20 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 11 286 11 286
2018-06-26 2018-06-22 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise −5 918 119 082 −4,73
2018-06-26 2018-06-22 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5 918 5 918 5,28 31 247 31 247
2018-02-28 2018-02-26 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 180 000 180 000
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
1 370 178
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
1 370 178
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)